These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16845259)

  • 21. Collagen shields as a drug delivery system for the fourth-generation fluoroquinolones.
    Kleinmann G; Larson S; Hunter B; Stevens S; Mamalis N; Olson RJ
    Ophthalmologica; 2007; 221(1):51-6. PubMed ID: 17183202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).
    Schlech BA; Alfonso E
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S7-15. PubMed ID: 16257313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboxymethyl cellulose stimulates rabbit corneal epithelial wound healing.
    Garrett Q; Xu S; Simmons PA; Vehige J; Xie RZ; Kumar A; Flanagan JL; Zhao Z; Willcox MD
    Curr Eye Res; 2008 Jul; 33(7):567-73. PubMed ID: 18600489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZO1 in corneal epithelium: association to the zonula occludens and adherens junctions.
    Sugrue SP; Zieske JD
    Exp Eye Res; 1997 Jan; 64(1):11-20. PubMed ID: 9093016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.
    Moshirfar M; Marx DP; Kumar R
    Cornea; 2005 Oct; 24(7):833-6. PubMed ID: 16160500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.
    Levine JM; Noecker RJ; Lane LC; Herrygers L; Nix D; Snyder RW
    J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization and expression of zonula occludins-1 in the rabbit corneal epithelium following exposure to benzalkonium chloride.
    Chen W; Hu J; Zhang Z; Chen L; Xie H; Dong N; Chen Y; Liu Z
    PLoS One; 2012; 7(7):e40893. PubMed ID: 22815857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corneal alternations induced by topical application of benzalkonium chloride in rabbit.
    Chen W; Li Z; Hu J; Zhang Z; Chen L; Chen Y; Liu Z
    PLoS One; 2011; 6(10):e26103. PubMed ID: 22022526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrophilic acrylic intraocular lens as a drug-delivery system for fourth-generation fluoroquinolones.
    Kleinmann G; Apple DJ; Chew J; Hunter B; Stevens S; Larson S; Mamalis N; Olson RJ
    J Cataract Refract Surg; 2006 Oct; 32(10):1717-21. PubMed ID: 17010873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal toxicity of moxifloxacin.
    Aydin E; Kazi AA; Peyman GA; Esfahani MR
    Retina; 2006 Feb; 26(2):187-90. PubMed ID: 16467676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells.
    Tsai TH; Chen WL; Hu FR
    Eye (Lond); 2010 May; 24(5):909-17. PubMed ID: 19648900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP; Caudle D; Aronowicz JD; Shine WE
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ophthalmic moxifloxacin (Vigamox) and gatifloxacin (Zymar).
    Med Lett Drugs Ther; 2004 Mar; 46(1179):25-7. PubMed ID: 15057188
    [No Abstract]   [Full Text] [Related]  

  • 34. Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections.
    Kim SJ; Toma HS
    Ophthalmology; 2011 Jul; 118(7):1358-63. PubMed ID: 21420176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.
    Solomon R; Donnenfeld ED; Perry HD; Snyder RW; Nedrud C; Stein J; Bloom A
    Ophthalmology; 2005 Mar; 112(3):466-9. PubMed ID: 15745775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The structure and viability analysis of corneal epithelial flap in the rabbit cornea after Epi-LASIK].
    Liu WF; DU ZY; Zhao WX; Huang Z; Liu DJ; Chen Y
    Zhonghua Yan Ke Za Zhi; 2007 Jul; 43(7):651-7. PubMed ID: 17897558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Area and depth of surfactant-induced corneal injury correlates with cell death.
    Jester JV; Li HF; Petroll WM; Parker RD; Cavanagh HD; Carr GJ; Smith B; Maurer JK
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):922-36. PubMed ID: 9579472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracameral moxifloxacin: in vitro safety on human ocular cells.
    Kernt M; Neubauer AS; Liegl RG; Lackerbauer CA; Eibl KH; Alge CS; Ulbig MW; A AK
    Cornea; 2009 Jun; 28(5):553-61. PubMed ID: 19421040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.